Hot inflation, rising oil and financing stress fractured technology leadership, while defensive groups kept sector breadth from collapsing sharply.
SS&C Technologies enters its October 22 update with stronger organic growth and cash flow, while leverage and recent price strength raise the proof bar.
MaxLinear’s Q2 growth shifted toward infrastructure, while the October 22 update will test margins, cash generation, inventory, and concentration.
CME Premium research: Record volume meets the October earnings test.
ABT Premium research: The October 21 evidence test.
RNG Premium research: The October 22 operating test.
URI Premium research: Scale meets a demanding earnings test.
Medpace’s strong second-quarter awards and cash profile face an October 21 test of backlog conversion, sponsor demand and margin durability.
SEIC Premium research: Scale, sales and the October conversion test.
Crown Castle tower economics face an October 21 test of revenue durability, organic leasing, tenant concentration and post-sale balance-sheet progress.
